Comparison of the 1% and 2% Pilocarpine mouthwash on xerostomic patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210208050302N1

Enrollment

Registered

2021-03-03

Start date

2021-04-09

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Xerostomia, oral medicine?dry mouth,saliva. ICD-10-CM Diagnosis Code R85.9

Interventions

Control group: Placebo.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: xerostomia

Exclusion criteria

Exclusion criteria: using chemical/herbal drugs pregnant/milking connective tissue disorders allergy to plocarpine

Design outcomes

Primary

Measure	Time frame
Saliva rate. Timepoint: in minute 45 & 60 & 75 in first and 14 days after intervention. Method of measurement: Absorbent method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactdr Babak Motamed

Islamic Azad University

motttamed@gmail.com+98 21 2232 6172

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026